Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial

Title:	Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Authors:	Shimura, Masahiko^{Aff1, IDs1038402401078y_cor1}; Oh, Hideyasu^Aff2; Ueda, Tetsuo^Aff3; Kitano, Shigehiko^Aff4; Mitamura, Yoshinori^Aff5; Sato, Junko^Aff6; Iwasaki, Keisuke^Aff6; Hirakata, Akito^Aff7
Source:	Japanese Journal of Ophthalmology: The Official International Journal of the Japanese Ophthalmological Society. 68(5):511-522
Database:	Springer Nature Journals